---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-033021"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2023-07-14T23:59:59+00:00"
generated_at: "2026-06-13T08:20:17.256863+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences stockholders elect directors, approve equity plan increase, ratify auditor

## Summary
- Quorum of 2,309,314 shares (>1/3 of 5,773,983 outstanding) present or proxy.
- Directors Jennifer Carver (1,281,109 for) and Curt LaBelle (1,280,290 for) elected to Class A.
- Approved amendment to 2021 Equity Incentive Plan: shares reserved increased from 68,288 to 648,678 (1,124,336 for).
- Ratified Baker Tilly US, LLP as auditor for fiscal year ending Dec 31, 2023 (1,981,630 for).

## SEC filing metadata
- accession: 0000950170-23-033021
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2023-07-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017023033021/0000950170-23-033021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017023033021/revb-20230714.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-033021
- JSON: https://secwatch.observer/filing/0000950170-23-033021.json
- Plain text: https://secwatch.observer/filing/0000950170-23-033021.txt

## Key facts
- Shareholder Votes
  REVELATION BIOSCIENCES, INC. shareholders approved Ratification of the Auditor at the 2023-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-31
  source text: Stockholders approved Baker Tilly US, LLP to audit our financial statements for the fiscal year ending December 31, 2023, based on the votes listed below: For Against Abstain 1,981,630 26,027 301,657
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023033021/0000950170-23-033021-index.htm
- Shareholder Votes
  REVELATION BIOSCIENCES, INC. shareholders approved Approval of to increase he number of shares reserved under the Company’s 2021 Equity Incentive Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Stockholders approved an amendment to the 2021 Equity Incentive Plan to increase the number of shares reserved under the Plan from 68,288 to 648,678, based on the votes listed below: For Against Abstain 1,124,336 224,337 15,961
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023033021/0000950170-23-033021-index.htm
- Shareholder Votes
  REVELATION BIOSCIENCES, INC. shareholders approved Election of Directors.
  - Proposal: director election
  - Outcome: passed
  source text: Stockholders approved to elect the two nominees for Class A director named herein to serve until the 2026 Annual Meeting or their successors are duly elected and qualified., based on the votes listed below: Director Nominee For Against Abstain Jennifer Carver 1,281,109 68,257 15,268 Curt LaBelle 1,280,290 66,949 17,395
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023033021/0000950170-23-033021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.